Company profile for Foresee Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Foresee Pharmaceuticals Co., Ltd. (FP) is a clinical-stage pharmaceutical company. Our mission is to serve patients. We strive to improve patients' quality of life and provide cure through innovative research. We are committed to apply the highest ethical standards to our products, services and communications. Foresee's core competency includes rapid development and commercialization of new drugs using its proprietary drug del...
Foresee Pharmaceuticals Co., Ltd. (FP) is a clinical-stage pharmaceutical company. Our mission is to serve patients. We strive to improve patients' quality of life and provide cure through innovative research. We are committed to apply the highest ethical standards to our products, services and communications. Foresee's core competency includes rapid development and commercialization of new drugs using its proprietary drug delivery technology as well as develop first-in-class NCE in disease areas of high unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
550 S college Ave, Suite 107, Newark, DE 19713, USA
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.contractpharma.com/breaking-news/foresee-pharmaceuticals-announces-fda-approval-of-camcevi-etm/

CONTRACTPHARMA
29 Aug 2025

https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-first-patient-dosed-in-the-phase-2-windward-study-of-the-aldh2-activator-mirivadelgat-for-patients-with-pulmonary-hypertension-associated-interstitial-lung-disease-ph-ild-302456261.html

PR NEWSWIRE
15 May 2025

https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-a-keynote-oral-presentation-and-participation-at-the-2025-american-thoracic-society-international-conference-302455406.html

PR NEWSWIRE
14 May 2025

https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-receives-the-third-positive-recommendation-from-the-dsmb-to-continue-the-casppian-study-302377863.html

PR NEWSWIRE
17 Feb 2025

https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-acceptance-of-an-abstract-for-presentation-at-asco-genitourinary-cancers-symposium-2025-302372207.html

PR NEWSWIRE
10 Feb 2025

https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-the-pdufa-goal-date-for-the-3-month-version-of-camcevi-is-august-29-2025-302349353.html

PR NEWSWIRE
13 Jan 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty